Install
Cell & Gene Therapies
CAR‑T, CRISPR, in vivo delivery, manufacturing, and long‑term follow‑up.
- 4 Tracked terms
- Last 30 days Feed window
What this topic collects on
An article joins this feed when it matches these terms. Each one is also a search of its own.
Related topics
Latest in Cell & Gene Therapies
News: CMN Moderates Panel Discussion at CSGCT 2026??? In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale
16+ hour, 55+ min ago (337+ words) CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CRISPR Medicine News CMN Moderates Panel Discussion at CSGCT 2026 – In Vivo CRISPR Medicine: From Scientific Promise to Patients at Scale CMN founder Jens-Ole…...
Exegenesis Bio, Modalis Partner to Advance CRISPR-Based DMD Therapy MDL-201
1+ day, 3+ hour ago (68+ words) 14 September 2026 | Monday | News The financial impact of this research collaboration on Modalis' results for the current fiscal year is expected to be immaterial, and there is no revision to the earnings forecast at this time. Two Chairs, 11,000 Kilometres Apart: The…...
Gene editing approach could provide lasting treatment for rare liver disease - study
1+ day, 17+ hour ago (270+ words) More than 500 different gene mutations can cause the disease, making mutation-specific treatments impractical. Researchers in Australia have developed a genome editing approach that could provide a more durable treatment for children with a rare genetic liver disorder. Researchers have taken…...
Aptamer-Guided CRISPR-Cas9 Delivery Could Make Cancer Genome Editing
1+ day, 15+ hour ago (55+ words) Gene editing has long promised a revolution in cancer medicine, yet the promise has remained stubbornly out of reach for one deceptively simple reason: getting the CRISPR-Cas9 machinery into tumor cells, and only tumor cells, is extraordinarily difficult. A new…...
Dogs May Not Respond to Thalidomide, Genetic Study Warns
1+ day, 23+ hour ago (656+ words) Thalidomide is one of the most infamous drugs in modern medicine, a sedative withdrawn from the market in 1961 after causing severe birth defects in thousands of children....
CRISPR Methylation Editing Rewrites the Cancer Epigenome Toward Causation
2+ day, 12+ hour ago (67+ words) Cancer has long been understood as a disease of the genome, driven by mutations that rewire the instructions encoded in DNA. Over the past three decades, however, a parallel truth has crystallized: cancer is equally a disease of the epigenome,…...
FDA clears trial of dual-targeted CAR T-cell therapy for cancer
2+ day, 21+ hour ago (778+ words) The U.S. Food and Drug Administration this week granted permission for investigators at the University of Colorado Anschutz to conduct a clinical trial testing genetically engineered immune cells in adults with advanced colorectal cancer and pediatric patients with solid cancers who…...
CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight
4+ day, 2+ hour ago (184+ words) New York, USA, Sept. 10, 2026 (GLOBE NEWSWIRE) -- CAR T-cell Therapy for NHL Clinical Trial Landscape Expands: Over 70 Companies Advancing Next-Generation Therapies | DelveInsight The CAR T-cell therapy for NHL clinical trial analysis report delivers important insights into ongoing research of 75+ pipeline CAR…...
$3.3 million NIH grant funds Upstate research into new immunotherapy for leukemia
4+ day, 53+ min ago (461+ words) Credit: SUNY Upstate Medical University Upstate immunologist Mobin Karimi, MD/PhD, has been awarded a $3.3 million grant to explore a new type of immunotherapy to treat acute myeloid leukemia. The grant comes from the National Cancer Institute of the National…...